title: Hyaluronan-Irinotecan improves progression-free survival in 5-fluorouracil refractory patients with metastatic colorectal cancer: a randomized phase II trial.
authors.affiliation: Department of Medical Oncology and Haematology, Royal Melbourne Hospital, Parkville, Melbourne, Australia.
authors.forename: Peter
authors.initials: P
authors.lastname: Gibbs
authors.forename: Philip R
authors.initials: PR
authors.lastname: Clingan
authors.forename: Vinod
authors.initials: V
authors.lastname: Ganju
authors.forename: Andrew H
authors.initials: AH
authors.lastname: Strickland
authors.forename: Shirley S
authors.initials: SS
authors.lastname: Wong
authors.forename: Niall C
authors.initials: NC
authors.lastname: Tebbutt
authors.forename: Craig R
authors.initials: CR
authors.lastname: Underhill
authors.forename: Richard M
authors.initials: RM
authors.lastname: Fox
authors.forename: Steven P
authors.initials: SP
authors.lastname: Clavant
authors.forename: Jenny
authors.initials: J
authors.lastname: Leung
authors.forename: Minh
authors.initials: M
authors.lastname: Pho
authors.forename: Tracey J
authors.initials: TJ
authors.lastname: Brown